Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr482 Inhibitors

Olr482 inhibitors represent a fascinating category of chemical compounds that interact specifically with the olfactory receptor 482 (Olr482), a G protein-coupled receptor (GPCR) predominantly expressed in the olfactory system. These inhibitors are designed to modulate the activity of Olr482 by binding to the receptor and altering its conformation, thereby inhibiting its ability to interact with specific odorant molecules. This inhibition is typically achieved through competitive or allosteric mechanisms, where the inhibitor either directly competes with the natural ligand for binding at the active site or induces conformational changes in the receptor that reduce its affinity for the ligand. The structural diversity of Olr482 inhibitors is considerable, with many compounds exhibiting varied chemical scaffolds, including heterocyclic rings, aromatic moieties, and other functional groups that contribute to their binding specificity and affinity.

In terms of chemical properties, Olr482 inhibitors often feature specific pharmacophores that enable their selective interaction with the receptor. These may include hydrogen bond donors and acceptors, hydrophobic pockets, and aromatic stacking interactions, all of which are crucial for the high affinity and selectivity observed in these inhibitors. Moreover, the design and synthesis of Olr482 inhibitors are driven by the need to optimize these interactions, often requiring a detailed understanding of the receptor's three-dimensional structure and the dynamics of its binding pocket. Advanced computational modeling and structure-activity relationship (SAR) studies play a significant role in this process, allowing researchers to predict and enhance the efficacy of these inhibitors. The study of Olr482 inhibitors also involves extensive in vitro assays to characterize their binding kinetics, receptor-ligand interactions, and overall inhibitory potency, providing valuable insights into the molecular mechanisms that govern olfactory signaling.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

Activates AMPK, potentially influencing metabolic pathways and proteins associated with them.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Targets multiple tyrosine kinases, potentially affecting proteins involved in cell signaling and growth.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Inhibits BCR-ABL tyrosine kinase, potentially affecting proteins in leukemia-associated pathways.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Multi-targeted tyrosine kinase inhibitor, potentially influencing proteins involved in angiogenesis and tumor growth.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Modulates autophagy, potentially influencing proteins involved in cellular degradation pathways.

GW501516

317318-70-0sc-202642
sc-202642A
1 mg
5 mg
$82.00
$179.00
28
(3)

Activates PPARδ, potentially influencing proteins associated with energy metabolism.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Inhibits EGFR tyrosine kinase, potentially affecting proteins in the EGFR signaling pathway.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$117.00
$423.00
11
(1)

Inhibits BRAF kinase, potentially affecting proteins involved in the MAPK/ERK pathway.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Inhibits proteasome, potentially affecting protein degradation and cell cycle regulation.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Inhibits Src family kinases, potentially influencing proteins in cell signaling pathways.